1. Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, Abernethy AP. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. The Oncologist 2018; 18(4): 381.## [DOI:10.1634/theoncologist.2012-0279] [PMID] []

2. Kuek T, Schilling CH, Choong PF. The impact of cost on quality of surgical management in non-metastatic extremity sarcoma: A cross-country narrative literature review with a systematic approach. ESMO Open 2021; 4(3): e000285. ##

3. Jalali M, Khodabakhshikoolaee A. Relationship between health literacy and general health amongpatients with leukemia before bone marrow transplant. Hospital Magazine 2018; 1(1): 1-7. ## [DOI:10.29252/ijca.1.1.1]

4. WHO. Cancer control: knowledge into action: WHO guides for effective programmes. WHO. Assessing national capacity for the prevention and control of NCDs. 2018. ##

5. Dickens C, Joffe M, Jacobson J, Venter F, Schüz J, Cubasch H, McCormack V. Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: a South African public hospital case series of over 1,000 women. International Journal of Cancer 2018; 135(9): 2173-82. ## [DOI:10.1002/ijc.28861] [PMID] []

6. Mariotto AB, Robin Yabroff K, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. Journal of the National Cancer Institute 2011; 103(2): 117-28. ## [DOI:10.1093/jnci/djq495] [PMID] []

7. Giordano SH, Niu J, Chavez‐MacGregor M, Zhao H, Zorzi D, Shih YC, Smith BD, Shen C. Estimating regimen‐specific costs of chemotherapy for breast cancer: Observational cohort study. Cancer. 2016 Nov 15;122(22):3447-55. ## [DOI:10.1002/cncr.30274] [PMID] []

8. Rezapour A, Jahangiri R, Olyaeemanesh A, Kalaghchi B, Nouhi M, Nahvijou A. The economic burden of oral cancer in Iran. PLoS ONE 2018; 13(9): e0203059. ## [DOI:10.1371/journal.pone.0203059] [PMID] []

9. Prager GW, Braga S, Bystricky B, Qvortrup C, Criscitiello C, Esin E, et al. Global cancer control: responding to the growing burden, rising costs and inequalities in access. ESMO Open 2018; 3(2): e000285. ## [DOI:10.1136/esmoopen-2017-000285] [PMID] []

10. Shahrjerdi R, EbrahimAbadi GH R, Shahbazi S. Evaluating the cost of quality and selecting the appropriate option for cost reduction using fuzzy AHP and fuzzy topsis models (case study: the water and wastewater company of markazi province). Journal of Water and Sustainable Development 2017; 4(2): 13-22. ##

11. Haddad M. Viewpoints of employed nurses in hospitals of birjand city regarding existing barriers in patient education. Modern Care Journal 2011; 8(3): 152-8. ##

12. Hofmarcher T, Brådvik G, Svedman C, Lindgren P, Jönsson B, Wilking N. Comparator report on cancer in europe 2019 - disease burden, costs and access to medicines. The PRIAS Study European Urology 2019; 63(4): 597-603. ##

13. Vahdatimanesh Z, Zendehdel K, Akbari Sari A, Farhan F, Nahvijou A, Delavari A, et al. Economic burden of colorectal cancer in the of Iran in 2012. Med J Islam Repub Iran 2017; 31: 115. ## [DOI:10.14196/mjiri.31.115] [PMID] []

14. Hair Jr, Hult GTM, Ringle C, Sarstedt M. A primer on partial least squares structural equation modeling, Critical Reviews in Oncology/Hematology 2016; 95(2): 133-43. ##

15. Baziar M. Investigating the direct treatment and non-treatment costs of cancer patients admitted to the Imam Khomeini Hospital Cancer Center in Tehran. Hospital Magazine 2012; 11(1): 39-50. ##

16. Wallwiener M, Brucker SY, Wallwiener D. Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certification. Archives of Gynecology and Obstetrics 2016; 285(6): 1671-83. ## [DOI:10.1007/s00404-011-2212-3] [PMID] []

17. Sullivan R, Alatise OI, Anderson BO, Audisio R, Autier P, Aggarwal A, et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. The Lancet Oncology 2017; 16(11): 1193-224. ## [DOI:10.1016/S1470-2045(15)00223-5] [PMID]

18. Dams E. National cancer control plan 2018-2028 suriname: Ministry of Health; 2018. ##

19. Gabriela Dieguez FS, Ferro C, Pyenson BS. A multi-year look at the cost burden of cancer care, American Health & Drug Benefits 2016; 9(1): 123-52. ##

20. Giordano SH, Niu J, Chavez‐MacGregor M, Zhao H, Zorzi D, Shih YC, et al. Estimating regimen‐specific costs of chemotherapy for breast cancer: Observational cohort study. Cancer 2016; 122(22): 3447-55. ## [DOI:10.1002/cncr.30274] [PMID] []

21. Gultekin M, Karaca MZ, Kucukyildiz I, Dundar S, Keskinkilic B, Turkyilmaz M. Mega hpv laboratories for cervical cancer control: Challenges and recommendations from a case study of Turkey. Papillomavirus Res 2019; 7: 118-22. ## [DOI:10.1016/j.pvr.2019.03.002] [PMID] []

22. Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, et al. European health systems and cancer care. Ann Oncol 2019; 14(5): 41-60. ## [DOI:10.1093/annonc/mdg753] [PMID]

23. Sayani A. Health Equity in National Cancer Control Plans: An Analysis of the Ontario; 2019. ## [DOI:10.15171/ijhpm.2019.40] [PMID] []

24. Weiser TG, Gawande A. Excess surgical mortality: strategies for improving quality of care. Journal of the National Comprehensive Cancer Network 2016; 14(7): 837-47. ##

25. Wesselmann S, Winter A, Ferencz J, Seufferlein T, Post S. Documented quality of care in certified colorectal cancer centers in Germany: German Cancer Society benchmarking report for 2013. International Journal of Colorectal Disease 2016; 29(4): 511-8. ## [DOI:10.1007/s00384-014-1842-x] [PMID]

26. Gomes B, Calanzani N, Koffman J, Higginson IJ. Is dying in hospital better than home in incurable cancer and what factors influence this? A population-based study. BMC Medicine 2015; 13(1): 1-4. ## [DOI:10.1186/s12916-015-0466-5] [PMID] []

27. Walshe C, Luker KA. District nurses' role in palliative care provision: a realist review. International Journal of Nursing Studies 2010; 47(9): 1167-83. ## [DOI:10.1016/j.ijnurstu.2010.04.006] [PMID]

28. Xiao X, Wu ZC, Chou KC. A multi-label classifier for predicting the subcellular localization of gram-negative bacterial proteins with both single and multiple sites. PloS One 2011; 6(6): e20592. ## [DOI:10.1371/journal.pone.0020592] [PMID] []

29. Bastedo SJ, Krzyzanowska MK, Moineddin R, Yun L, Enright KA, Grunfeld E. A population-based assessment of primary care visits during adjuvant chemotherapy for breast cancer. Current Oncology 2017; 24(2): 90-4. ## [DOI:10.3747/co.24.3431] [PMID] []

30. Easley J, Miedema B, O'Brien MA, Carroll J, Manca D, Webster F, Grunfeld E. The role of family physicians in cancer care: perspectives of primary and specialty care providers. Current Oncology 2017; 24(2): 75-80. ## [DOI:10.3747/co.24.3447] [PMID] []